Drawing for HOOGA

USPTO serial 88053180

HOOGA

Reviewed by CopyMark Law Group

Status 760
Filing date
Status date
Registration date
—
Examiner
DESAI, BRIN ANDERSON
Law office
TMO LAW OFFICE 113

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with HOOGA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

NATHANIEL L FINTZ

NATHANIEL L FINTZ ZUBER LAWLER LLPONE PENN PLAZASUITE 4430NEW YORK, NY 10119

Goods and services

ClassDescriptionStatusFirst use
003Electronic cigarette liquid (e-liquid) comprised of essential oils, not including cannabis or cannabis-related substances, all the foregoing not including any goods noncompliant with U.S. federal lawACTIVE—
005Herbal tinctures for medical purposes, not including marijuana or marijuana-related substances, all the foregoing not including any goods noncompliant with U.S. federal law; Herbal tinctures for medical purposes, not including marijuana or marijuana-related substances, all the foregoing not including any goods noncompliant with U.S. federal law, all the foregoing containing, as an inactive ingredient, CBD solely derived from hemp with a delta-9 tetrahydrocannabinol concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods not conforming to an OTC Monograph; Herbal tinctures for medical purposes, not including marijuana or marijuana-related substances, all the foregoing not including any goods noncompliant with U.S. federal law, all the foregoing containing CBD solely derived from hemp with a delta-9 tetrahydrocannabinol concentration of not more than 0.3% on a dry weight basis, the foregoing containing only naturally-occurring trace levels of CBD; Herbal tinctures for medical purposes, not including marijuana or marijuana-related substances, all the foregoing not including any goods noncompliant with U.S. federal law, all the foregoing not containing any cannabis or cannabinoids; Medicinal preparations for the mouth to be applied in the form of capsules, not including marijuana or marijuana-related substances, all the foregoing not including any goods noncompliant with U.S. federal law; Medicinal preparations for the mouth to be applied in the form of capsules, not including marijuana or marijuana-related substances, all the foregoing not including any goods noncompliant with U.S. federal law, all the foregoing containing, as an inactive ingredient, CBD solely derived from hemp with a delta-9 tetrahydrocannabinol concentration of not more than 0.3% on a dry weight basis, the foregoing not including any goods not conforming to an OTC Monograph; Medicinal preparations for the mouth to be applied in the form of capsules, not including marijuana or marijuana-related substances, all the foregoing not including any goods noncompliant with U.S. federal law, all the foregoing containing CBD solely derived from hemp with a delta-9 tetrahydrocannabinol concentration of not more than 0.3% on a dry weight basis, the foregoing containing only naturally-occurring trace levels of CBD; Medicinal preparations for the mouth to be applied in the form of capsules, not including marijuana or marijuana-related substances, all the foregoing not including any goods noncompliant with U.S. federal law, all the foregoing not containing any cannabis or cannabinoids; Orally-consumed nutritional supplements in the form of capsules, not including marijuana or marijuana-related substances, all the foregoing not including any goods noncompliant with U.S. federal law; Orally-consumed nutritional supplements in the form of capsules, not including marijuana or marijuana-related substances, all the foregoing not including any goods noncompliant with U.S. federal law, all the foregoing containing CBD solely derived from hemp with a delta-9 tetrahydrocannabinol concentration of not more than 0.3% on a dry weight basis, the foregoing containing only naturally-occurring trace levels of CBD; Orally-consumed nutritional supplements in the form of capsules, not including marijuana or marijuana-related substances, all the foregoing not including any goods noncompliant with U.S. federal law, all the foregoing not containing any cannabis or cannabinoids; Specialized tablets, capsules and powders for the delivery of pharmaceuticals sold without the pharmaceutical ingredient, not including marijuana or marijuana-related substances, all the foregoing not including any goods noncompliant with U.S. federal law; Specialized tablets, capsules and powders for the delivery of pharmaceuticals sold without the pharmaceutical ingredient, not including marijuana or marijuana-related substances, all the foregoing not including any goods noncompliant with U.S. federal law, all the foregoing containing CBD solely derived from hemp with a delta-9 tetrahydrocannabinol concentration of not more than 0.3% on a dry weight basis, the foregoing containing only naturally-occurring trace levels of CBD; Specialized tablets, capsules and powders for the delivery of pharmaceuticals sold without the pharmaceutical ingredient, not including marijuana or marijuana-related substances, all the foregoing not including any goods noncompliant with U.S. federal law, all the foregoing not containing any cannabis or cannabinoidsACTIVE—
032powders used in the preparation of soft drinks, not including cannabis or cannabis-related substances, all the foregoing not including any goods noncompliant with U.S. federal law; powders for making soft drinks or tea-flavored beverages, not including cannabis or cannabis-related substances, all the foregoing not including any goods noncompliant with U.S. federal lawACTIVE—
034Chemical flavorings in liquid form used to refill electronic cigarette cartridges, not including marijuana or marijuana-related substances, all the foregoing not including any goods noncompliant with U.S. federal law; Chemical flavorings in liquid form used to refill electronic cigarette cartridges, not including marijuana or marijuana-related substances, all the foregoing not including any goods noncompliant with U.S. federal law, all the foregoing solely derived from hemp with a delta-9 tetrahydrocannabinol concentration of not more than 0.3% on a dry weight basis; Chemical flavorings in liquid form used to refill electronic cigarette cartridges, not including marijuana or marijuana-related substances, all the foregoing not including any goods noncompliant with U.S. federal law, all the foregoing not containing any cannabis or cannabinoids; Electronic cigarettes, not including marijuana or marijuana-related substances, all the foregoing not including any goods noncompliant with U.S. federal law; Electronic cigarettes, not including marijuana or marijuana-related substances, all the foregoing not including any goods noncompliant with U.S. federal law, all the foregoing solely derived from hemp with a delta-9 tetrahydrocannabinol concentration of not more than 0.3% on a dry weight basis, all the foregoing solely for use with goods solely derived from hemp with a delta-9 tetrahydrocannabinol concentration of not more than 0.3% on a dry weight basis; Electronic cigarettes, not including marijuana or marijuana-related substances, all the foregoing not including any goods noncompliant with U.S. federal law, all the foregoing not containing any cannabis or cannabinoids; Cartridges sold filled with vegetable glycerin for electronic cigarettes, not including marijuana or marijuana-related substances, all the foregoing not including any goods noncompliant with U.S. federal law; Cartridges sold filled with vegetable glycerin for electronic cigarettes, not including marijuana or marijuana-related substances, all the foregoing not including any goods noncompliant with U.S. federal law, all the foregoing solely derived from hemp with a delta-9 tetrahydrocannabinol concentration of not more than 0.3% on a dry weight basis; Cartridges sold filled with vegetable glycerin for electronic cigarettes, not including marijuana or marijuana-related substances, all the foregoing not including any goods noncompliant with U.S. federal law, all the foregoing not containing any cannabis or cannabinoidsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 16, 2021DOCKASSIGNED TO EXAMINER—
Feb 26, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 26, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 24, 2021ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Feb 24, 2021EXPIEX PARTE APPEAL-INSTITUTED—
Feb 24, 2021JURTJURISDICTION RESTORED TO EXAMINING ATTORNEY—
Feb 24, 2021EXAFEXPARTE APPEAL RECEIVED AT TTAB—
Feb 22, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 22, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 22, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Aug 27, 2020GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Aug 27, 2020GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Aug 27, 2020CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Aug 5, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 5, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 5, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 5, 2020GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 5, 2020GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 5, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 10, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 10, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 10, 2020ALIEASSIGNED TO LIE—
Dec 18, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 18, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 18, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 18, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 18, 2019DOCKASSIGNED TO EXAMINER—
Aug 7, 2018DOCKASSIGNED TO EXAMINER—
Jul 31, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 30, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance